SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-23-279836
Filing Date
2023-11-17
Accepted
2023-11-17 16:39:38
Documents
5
Effectiveness Date
2023-11-17

Document Format Files

Seq Description Document Type Size
1 S-8 d609325ds8.htm S-8 49099
2 EX-5.1 d609325dex51.htm EX-5.1 9853
3 EX-23.2 d609325dex232.htm EX-23.2 1753
4 EX-FILING FEES d609325dexfilingfees.htm EX-FILING FEES 30867
5 GRAPHIC g609325g1117003952726.jpg GRAPHIC 2308
  Complete submission text file 0001193125-23-279836.txt   96140
Mailing Address 2000 SIERRA POINT PARKWAY SUITE 400 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY SUITE 400 BRISBANE CA 94005 415-798-8589
Tempest Therapeutics, Inc. (Filer) CIK: 0001544227 (see all company filings)

IRS No.: 451472564 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-275637 | Film No.: 231419404
SIC: 2834 Pharmaceutical Preparations